Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122362062 | 12236206 | 2 | F | 20160310 | 20160704 | 20160404 | 20160713 | EXP | PHHY2016FR041141 | SANDOZ | 72.54 | YR | F | Y | 0.00000 | 20160713 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122362062 | 12236206 | 1 | I | BISOPROLOL SANDOZ | BISOPROLOL | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 122362062 | 12236206 | 2 | PS | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 1 DF, QD | Y | U | 76397 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122362062 | 12236206 | 1 | Blood pressure abnormal |
| 122362062 | 12236206 | 2 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122362062 | 12236206 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122362062 | 12236206 | Asthenia | |
| 122362062 | 12236206 | Drug ineffective | |
| 122362062 | 12236206 | Drug interaction | |
| 122362062 | 12236206 | Hypertension | |
| 122362062 | 12236206 | Migraine |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122362062 | 12236206 | 1 | 20160201 | 0 | ||
| 122362062 | 12236206 | 2 | 201509 | 20160322 | 0 |